Pre-Clinical Models of Infectious Diseases - On-Ramping of potential new contractors.
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Ignacio Reyes ignacio.reyes@nih.gov (301) 435-7574
- William Florence clint.florence@nih.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health (NIH) is forecasting a new requirement to on-ramp new contractors into its Preclinical Models of Infectious Diseases (PCMID-24) multiple-award IDIQ contract, with an estimated solicitation release date of 2026-09-01 and an estimated award date of 2026-10-01. The on-ramp targets Biosecurity Level 3 and Level 4 capable performers, fungal model providers of interest to NIAID, and Novel Alternative Models (NAMs) experience, because the current pool lacks BSL-4 capable contractors and NAM expertise, and NIAID states it cannot expand access to BSL-3 Regional Biocontainment laboratories or fungal pathogen testing capacity without them. The forecast is a new requirement with no set-aside used, under NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology).
The Contracting Officer anticipates approximately 10 new contractors across multiple task areas of PCMID-24 and may announce the ramp-on period at any time during the IDIQ's effective period, no earlier than one year from the date of award, after annual review of the total contractor count. The forecast lists an estimated award value range of 10000 to 25000. Points of contact are Ignacio Reyes, Contracting Officer, at ignacio.reyes@nih.gov or +13014357574, and William Florence, listed with the email clint.florence@nih.gov.
Forecast text
In 2024, multiple institutions were awarded base contracts under the Preclinical Models of Infectious Diseases IDIQ contract program. Its overarching goal was to provide capability in a broad range of animal and animal replacement models to evaluate the efficacy of promising candidate countermeasures (vaccines, therapeutics, diagnostics) against the full range of infectious agents that are in the purview of DMID. The breadth of the existing contractor pool has enabled a rapid and effective response to emerging infectious diseases such, and other emergency preparedness priorities.
The Contracting Officer (CO) will review every year the total number of contractors to ensure adequate competition for task orders throughout the ordering period the multiple award IDIQ contract. The total number of contractors may fluctuate due to various reasons, such as general economic conditions, or other reasons. If the CO determines that it is in the best interest of the government to "Ramp On" to the multiple award IDIQ contract new Contractors, the CO has the discretion to announce "Ramp On" period at any time during the effective period of the multiple award IDIQ contract, but no earlier than one year from date of award. This request to begin the process of on-ramping potential new contractors for the PCMID IDIQ to increase multiple areas of expertise, such as, but not limited to: Contractors who operate at a Biosecurity Level 3 and 4, those who offer fungal models of interest to NIAID and Novel Alternative Models (NAMs). NIAID anticipates ~10 new contractors to be on-ramped into the contractor pool of multiple Task Areas of PCMID-24.
In the absence of on-ramping potential contractors/performers, NIAID would be unable to expand access and availability of BSL-4 testing capacity since the current pool does not contain key performers which are BSL-4 capable, access BSL-3 Regional Biocontainment laboratories (RBLs), expand capacity and capability for testing interventions against fungal pathogens in pre-clinical small animal models and finally expanded breadth, capacity and capability of available Novel Alternative Models (NAMs) since the current pool does not contain key contractors which have significant experience in NAMs.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast